330 results on '"Teopiz, Kayla M."'
Search Results
2. Effect of RANKL on Lower Depressive Symptoms In Hemodialysis Patients
3. Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine
4. Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023
5. Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis
6. Correction: Subjective and objective measures of cognitive function are correlated in persons with Post-COVID-19 Condition: a secondary analysis of a Randomized Controlled Trial
7. Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine
8. Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis
9. Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials
10. Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysis
11. Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis
12. The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS)
13. The role of KCNQ channel activators in management of major depressive disorder
14. Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis
15. Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis
16. Effects of ketamine on metabolic parameters in depressive disorders: A systematic review
17. Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis
18. Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic review
19. Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review
20. A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review
21. Childhood maltreatment and subsequent depressive symptoms: a prospective study of the sequential mediating role of self-esteem and internalizing/externalizing problems
22. Evaluation of a novel instrument for detecting bipolar disorders in China: The Rapid Mood Screener (RMS)
23. Association of SARS-CoV-2 infection with neurological impairments in pediatric population: A systematic review
24. Association between rumination, suicidal ideation and suicide attempts in persons with depressive and other mood disorders and healthy controls: A systematic review and meta-analysis
25. Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder
26. Brain structural and functional alterations in individuals with combined overweight/obesity and mood disorders: A systematic review of neuroimaging studies
27. Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review
28. A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review
29. Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder
30. Associations of stressful life events with subthreshold depressive symptoms and major depressive disorder: The moderating role of gender
31. The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression
32. Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis
33. Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the united states food and drug administration adverse event reporting system (FAERS)
34. Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system
35. Impact of Elevated Body Mass Index (BMI) on Cognitive Functioning and Inflammation in Persons with Post-COVID-19 Condition: A Secondary Analysis
36. Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis
37. Evaluating cognitive function in unaffected relatives of individuals with bipolar disorders: A meta-analysis
38. Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
39. The psychological factors mediating/moderating the association between childhood adversity and depression: A systematic review
40. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
41. Association between childhood trauma and medication adherence among patients with major depressive disorder: the moderating role of resilience
42. The association of FKBP5 gene methylation, adolescents’ sex, and depressive symptoms among Chinese adolescents: a nested case-control study
43. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
44. Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence
45. Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis.
46. Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a post-hoc analysis: Anhedonia and psychosocial functioning in post-COVID-19 condition.
47. Psychometric Properties of the Korean Version of THINC-integrated Tool (THINC-it-K): A Tool for Screening Assessment of Cognitive Function in Patients with Major Depressive Disorder.
48. Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects
49. The Impact of Cognitive Function on Health-Related Quality of Life in Persons with Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine
50. Longitudinal Association between Stressful Life Events and Suicidal Ideation in Adults with Major Depression Disorder: The Mediating Effects of Insomnia Symptom
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.